Its analytical performance was successfully evaluated by Wan et al. They reported the performance verification of SARS-CoV-2 IgM (82% sensitivity and 93.85% specificity) and SARS-CoV-2 IgG (86% sensitivity and 96.92% specificity) detection kits among COVID-19 patients [20]. The gene discussed is CD40LG; the disease is COVID-19.